This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, National Institute of Health and Medical Research, Scientiam Pharma. Active years: 2022-2026.
Location History:
- Saulx les Chartreux, FR (2022)
- Saulx-les-Chartreux, FR (2024)
Company Filing History:
3 out of 8,807 
1 out of 1,853 
1 out of 1 
Years Active: 2022-2026
Title: Narciso Costa: Innovator in Antibody Research
Introduction
Narciso Costa is a notable inventor based in Saulx-les-Chartreux, France. He has made significant contributions to the field of biomedical research, particularly in the development of antibodies for therapeutic applications.
Latest Patents
Narciso Costa holds a patent for an "Antibody against the endothelin receptor subtype A, and uses thereof." This invention focuses on antibodies, especially monoclonal antibodies, fragments, or derivatives that target the endothelin receptor subtype A. The patent outlines the therapeutic and diagnostic uses of this antibody, particularly in the context of cancers such as glioblastoma.
Career Highlights
Throughout his career, Narciso Costa has worked with prominent organizations, including the Commissariat à L'Énergie Atomique Et Aux Énergies Alternatives and Université Paris Cité. His work has been instrumental in advancing research in the field of cancer treatment.
Collaborations
Narciso Costa has collaborated with notable colleagues, including Didier Boquet and Amaury Herbet. These partnerships have contributed to the success of his research endeavors.
Conclusion
Narciso Costa's innovative work in antibody research highlights his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in cancer treatment.